Irrespective of powerful therapeutic potential, LSD analogues encounter challenges. Regulatory boundaries and psychedelics-linked stigma hinder widespread adoption. Profound ordeals necessitate watchful integration and help for favourable outcomes. Greatly regarded, 1P-LSD’s propionyl group positions it as being a structurally analogous pr